NEOGEN CORP of LANSING, MI filed a DEF 14A with the SEC on 2025-09-12. Industry: In Vitro & In Vivo Diagnostic Substances.
Showing 15 of 25 documents.
| Seq | Type | Description |
|---|---|---|
| 1 | DEF 14A | DEF 14A |
| 2 | GRAPHIC | GRAPHIC |
| 3 | GRAPHIC | GRAPHIC |
| 4 | GRAPHIC | GRAPHIC |
| 5 | GRAPHIC | GRAPHIC |
| 6 | GRAPHIC | GRAPHIC |
| 7 | GRAPHIC | GRAPHIC |
| 8 | GRAPHIC | GRAPHIC |
| 9 | GRAPHIC | GRAPHIC |
| 10 | GRAPHIC | GRAPHIC |
| 11 | GRAPHIC | GRAPHIC |
| 12 | GRAPHIC | GRAPHIC |
| 13 | GRAPHIC | GRAPHIC |
| 14 | GRAPHIC | GRAPHIC |
| 15 | GRAPHIC | GRAPHIC |
Showing 12 of 60 filings.
| Filed | Form |
|---|---|
| 2026-08-21 | DEFA14A |
| 2026-08-21 | DEF 14A |
| 2025-09-12 | DEFA14A |
| 2025-09-12 | DEF 14A |
| 2024-09-13 | DEF 14A |
| 2023-09-18 | DEF 14A |
| 2022-08-30 | DEF 14A |
| 2022-08-18 | 425 |
| 2022-08-17 | 425 |
| 2022-08-12 | 425 |
| 2022-08-05 | 425 |
| 2022-07-18 | DEFM14A |